UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in INVA — Innoviva, Inc.
CIK 861177
NEW YORK, NY
Position in INVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,257,177
+$121,674 QoQ
Shares Held
143,425
+6.6% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. INVA ranks #82 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in INVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,257,177 | 143,425 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,135,503 | 134,571 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,477,858 | 123,955 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,975,926 | 108,270 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,269,203 | 212,504 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,102,331 | 171,116 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,434,621 | 140,324 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,538,279 | 131,449 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,532,321 | 154,410 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $686,468 | 45,044 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $722,696 | 45,056 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $904,855 | 69,658 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $950,674 | 74,680 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $840,149 | 74,680 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $861,116 | 64,990 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $661,385 | 56,967 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $998,364 | 67,640 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,167,925 | 60,358 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,041,174 | 60,358 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $779,770 | 46,665 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $598,299 | 44,616 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $622,439 | 52,087 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,115,371 | 90,022 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $940,728 | 90,022 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $920,834 | 65,868 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $941,469 | 80,057 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||